News Archive

The program of the largest scientific German infection prevention and control congress in 2016 includes oral presentations and posters by Dr. Brill + Partner GmbH Institut für Hygiene und Mikrobiologie. The 13th conference of the German Society for Hospital Hygiene (DGKH) will take place from 10th to 13th of April 2016 in Berlin. Below please find an overview of our contributions at the congress (German language only):Oral presentations:11.04.2016, 09:45-11:15 - Salon 16/17Workshop: Validierung der Aufbereitung von Medizinprodukten- Validierung manueller Aufbereitungsprozesse von Medizinprodukten – gesetzliche und normative Grundlagen (F. H. H. Brill, Hamburg)- Validierung der bakteriziden und levuroziden Desinfektionsleistung eines Tuchsystems zur Aufbereitung vaginaler Ultraschallsonden (F. H. H. Brill, Hamburg)11.04.2016, 11:45-13:15 - Salon 16/17Workshop: Aufbereitung von Ultraschallsonden – Trends und Entwicklungen- HPV-Übertragung durch endokavitäre Ultraschallsonden – was wissen wir? (J. Steinmann, Bremen)11.04.2016, 16:45-18:15 - Saal BerlinSymposium: Aufbereitung und Reinigung - Teil 2- Praxisnahe Untersuchungen zur Viruzidie bei der Aufbereitung von Ultraschallsonden (J. Steinmann, Bremen)12.04.2016, 14:30-16:00 - Salon 16/17Workshop: Aspekte der Flächendesinfektion in Gegenwart und Zukunft- Bedeutung der Biozidgesetzgebung für die Flächendesinfektion (M. Hintzpeter, Hamburg)Poster:Medizinprodukte und antimikrobielle MaterialienP18: Prüfung der Dekolonisierung von Harnwegskathetern im praxisnahen in-vitro PrüfverfahrenReinigung und FlächendesinfektionP31: Bakterizide und viruzide Wirksamkeit verschiedener Flächendesinfektionsmittel im 4-Felder-Test in Anlehnung an DIN EN 16615 P32: Untersuchungen zur methodischen Weiterentwicklung des 4-Felder-Tests auf Basis der DIN EN 16615 zum viruziden und bakteriziden Wirksamkeitsnachweis von FlächendesinfektionstüchernP33: Eignung von Enterococcus faecalis als Testorganismus zur Evaluierung der in vivo Wirksamkeit alkoholbasierter HandtücherP34: Mikrobiologische Herausforderungen mit Antrocknungsverlusten gram-negativer Bakterien auf Edelstahl und deren LösungScientific Program 2016:http://www.krankenhaushygiene.de/veranstaltungen/2016/2016programm/

Professor Didier Pittet's work saves 5 to 8 million lives every year by focusing on hand hygiene in hospitals. In this fascinating talk he explains the global success of this ongoing campaign. Click here to watch the video: http://tinyurl.com/AdaptToAdopt

We proudly announce that we have been appointed as a project partner of the LeTriWa project. This project is coordinated by the Federal Environment Agency and deals with the retrospectively and prospectively data interpretation of test results on legionella bacteria in drinking water. The goal of the project is to identify risk factors as well as epidemiological conclusions from the data. Dr. Florian H. H. Brill has been appointed as a representative of the VUP e.V. to the advisory board of the project committee.

Heute erschienen: Das Magazin hamburger wirtschaft mit einem Artikel über unser Engagement in Dubai - "Auf Expansionskurs im Nahen Osten", hamburger wirtschaft, das Mitgliedermagazin der Handelskammer Hamburg, Ausgabe 02/2016, Seite 42 - 43. Link: hier

We are proud to announce that we could sign an important Memorandum of Understanding (MoU) with Thumbay Marketing & Distribution Company (TMDC), the marketing and distribution company owned and operated by Thumbay Group. According to the MoU, TMDC will represent our Infection Control Accreditation Program (ICAP) in the MENA region.The MoU was signed by Mr. Akbar Moideen Thumbay, Vice President of the Healthcare Division of Thumbay Group, on behalf of TMDC and Dr. Florian H. H. Brill. The MoU was signed in the presence of H.E. Elke Badde – Undersecretary of Health and Consumer Protection of the Free and Hanseatic City of Hamburg, Dr. Hans-Joerg Schmidt Trenz – CEO of Hamburg Chamber of Commerce as well as representatives of healthcare companies and service providers from Hamburg.Mr. Akbar Moideen Thumbay said, “TMDC is happy to represent Dr. Brill’s ICAP program in the MENA region. We are glad that H.E. Elke Badde was here to witness this landmark partnership. We hope that this new association would embark on many more mutually beneficial ventures, in the future.” H.E. Elke Badde and Prof. Dr. Hans-Joerg Schmidt Trenz, in their greeting remarks assured their continuous support for the new cooperation between Thumbay Group and Dr. Brill Group.About Thumbay GroupThumbay Group is an international business conglomerate headquartered in DIFC – Dubai. The Group has successfully diversified into 13 different sectors in a span of just 17 years. The Group today employs more than 3000 people, which will rise to 6000 with the completion of ongoing projects in the next two years, and to 15,000 employees by the end of 2020. The Gulf Medical University, the leading private medical university in the region owned and operated by Thumbay Group has a student cohort of over 73 nationalities and faculty and staff from over 22 countries. The Thumbay chain of hospitals, the constituent teaching hospitals of the Gulf Medical University, is one of the largest healthcare services provider in the UAE, serving over 2500 patients daily, from more than 175 countries. Apart from being an acknowledged leader in the health sector, Thumbay Group operates a reputed pharmacy chain, diagnostic centres, multi-brand retail outlets, world-class wellness centres, a prestigious chain of coffee shops, restaurants, popular health & lifestyle publication, etc.

Dr. Florian Brill and Mr. Steffen Pahl look forward to meet you at this year’s Arab Health. We are located at the North German joint pavilion of Life Science Nord Z3H35. For more information please click here.

Dr. Brill + Partner Institute for Hygiene and Microbiology will exhibit at the world’s largest medical technology exhibition MEDICA between 16/11 and 19/11/2015 in Dusseldorf. Please visit us on the joint pavillon of Life Science Nord and WTSH in Hall 15, Booth G40, or contact us for a visit at your booth. All details can be found here: LinkBetween January 25 and 28, 2016 we will also be an exhibitor on the Arab Health in Dubai, United Arab Emirates. Further details will follow.

The first "Conference of Applied Hygiene, Microbiology and Virology" was a great success. More than 80 participants from 17 countries have joined the scientific conference and its hanseatic supporting program on two days. National and international experts have presented their valuable insights and know how. The organizers Dr. Brill + Partner and Life Science Nord are very satisfied with the conference and therefore are proud to announce that the conference will be held on 6. - 7. October 2016 again. Please mark the date already. Further information will follow soon. An overview of all our events can be found here: Events

We are more than happy to inform that we started a cooperation in the field of biocorrosion of concrete and plastics with Fraunhofer Institute for Environmental, Safety, and Energy Technology UMSICHT. Our partners: Partners

We are proud to announce that we could sign a partnership cooperation agreement with BioGenius. A leading chemical-physical analytics laboratory for biocidal and plant protection products. In addition, they are experts for efficacy testing of insecticides. Our partners: Partners

In our new market in the UAE we were able to sign a cooperation contract with one of the leading laboratories for chemical  and physical analysis PSN of food and environmental samples. Our partners: Partners

Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology proudly announces that we received a research grant within the EU research fund Horizon 2020. The project is called "MicroArctic" and is focused and the microbiological characterization of the microbiological ecology of extreme habitats such as Greenland, Siberia etc. including the influence of global warming. We will employ after project start in 2016 a PhD student in cooperation with University of Potsdam for three years. The PhD student will focus on the characterization of pathogenic bacteria.